Home
ACCD
ACCD News

Latest Accolade Inc. (ACCD) News on March 26, 2025

Do Options Traders Know Something About Accolade (ACCD) Stock We Don't?

Zacks

13 days ago

Do Options Traders Know Something About Accolade (ACCD) Stock We Don't?

Accolade Welcomes Oshi Health to Trusted Partner Ecosystem

PR Newswire

20 days ago

Accolade Welcomes Oshi Health to Trusted Partner Ecosystem

Investing.com

21 days ago

Piper Sandler downgrades Accolade ahead of shareholder vote

MT Newswires

21 days ago

Piper Sandler Downgrades Accolade to Neutral From Overweight, $9 Price Target

Has Accolade (ACCD) Outpaced Other Business Services Stocks This Year?

Zacks

22 days ago

Has Accolade (ACCD) Outpaced Other Business Services Stocks This Year?

Transcarent and Accolade Announce Expiration of Hart-Scott Rodino Waiting Period for Pending Merger Transaction

GlobeNewswire

a month ago

Transcarent and Accolade Announce Expiration of Hart-Scott Rodino Waiting Period for Pending Merger Transaction

Accolade Expands Virtual Care to Medicare Beneficiaries Nationwide Through PlushCare Direct-to-Consumer Offering

PR Newswire

2 months ago

Accolade Expands Virtual Care to Medicare Beneficiaries Nationwide Through PlushCare Direct-to-Consumer Offering

Why Accolade Inc (ACCD) Is Skyrocketing So Far In 2025

Insider Monkey

2 months ago

Why Accolade Inc (ACCD) Is Skyrocketing So Far In 2025

Dell Technologies, Accolade, and More Stocks See Action From Activist Investors

Barrons.com

2 months ago

Dell Technologies, Accolade, and More Stocks See Action From Activist Investors

Is Accolade, Inc. (ACCD) the Hottest Smid-Cap Stock So Far In 2025?

Insider Monkey

2 months ago

Is Accolade, Inc. (ACCD) the Hottest Smid-Cap Stock So Far In 2025?

MT Newswires

2 months ago

Stephens Downgrades Accolade to Equalweight From Overweight, Trims Price Target to $7.03 From $8

Accolade (ACCD) Reports Q3 Loss, Lags Revenue Estimates

Zacks

3 months ago

Accolade (ACCD) Reports Q3 Loss, Lags Revenue Estimates

Associated Press Finance

3 months ago

Accolade: Fiscal Q3 Earnings Snapshot

MT Newswires

3 months ago

Truist Securities Downgrades Accolade to Hold From Buy

Transcarent to acquire health advocacy and primary care company Accolade for $621m

Hospital Management

3 months ago

Transcarent to acquire health advocacy and primary care company Accolade for $621m

Accolade to be acquired by Transcarent for $7.03 per share in cash

TipRanks

3 months ago

Accolade to be acquired by Transcarent for $7.03 per share in cash

MT Newswires

3 months ago

Leerink Partners Downgrades Accolade to Market Perform From Outperform, Adjusts Price Target to $7.03 From $9.50

MT Newswires

3 months ago

Raymond James Downgrades Accolade to Market Perform From Outperform

MT Newswires

3 months ago

William Blair Downgrades Accolade to Market Perform From Outperform

MT Newswires

3 months ago

Needham Downgrades Accolade to Hold From Buy

MT Newswires

3 months ago

Stifel Downgrades Accolade to Hold From Buy, Adjusts Price Target to $7.03 From $8

MT Newswires

3 months ago

Morgan Stanley Adjusts Price Target on Accolade to $5 From $6

Accolade to Announce Fiscal Third Quarter 2025 Financial Results

GlobeNewswire

3 months ago

Accolade to Announce Fiscal Third Quarter 2025 Financial Results

Accolade (ACCD) Upgraded to Buy: Here's Why

Zacks

4 months ago

Accolade (ACCD) Upgraded to Buy: Here's Why

Accolade And 2 Other US Penny Stocks With Growth Potential

Simply Wall St.

4 months ago

Accolade And 2 Other US Penny Stocks With Growth Potential

Accolade To Present at Upcoming Investor Conferences

GlobeNewswire

4 months ago

Accolade To Present at Upcoming Investor Conferences

Accolade And 2 Other Penny Stocks To Watch On US Exchanges

Simply Wall St.

5 months ago

Accolade And 2 Other Penny Stocks To Watch On US Exchanges

Accolade (ACCD) Loses -15.57% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Zacks

5 months ago

Accolade (ACCD) Loses -15.57% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Accolade Welcomes Renalogic to Trusted Partner Ecosystem

PR Newswire

5 months ago

Accolade Welcomes Renalogic to Trusted Partner Ecosystem

Accolade (ACCD) Upgraded to Buy: Here's What You Should Know

Zacks

6 months ago

Accolade (ACCD) Upgraded to Buy: Here's What You Should Know

Accolade Second Quarter 2025 Earnings: Beats Expectations

Simply Wall St.

6 months ago

Accolade Second Quarter 2025 Earnings: Beats Expectations

Accolade Inc (ACCD) Q2 2025 Earnings Call Transcript Highlights: Strong Revenue and Cash Flow ...

GuruFocus.com

6 months ago

Accolade Inc (ACCD) Q2 2025 Earnings Call Transcript Highlights: Strong Revenue and Cash Flow ...

Thomson Reuters StreetEvents

6 months ago

Q2 2025 Accolade Inc Earnings Call

MT Newswires

6 months ago

Accolade Shares Rise After Fiscal Q2 Net Loss Narrows, Revenue Rises; Sets Q3 Guidance, Reiterates 2025 Outlook

Accolade's Q2 Boost: Revenue Rises, Losses Shrink, And Profitability Looms

Benzinga

6 months ago

Accolade's Q2 Boost: Revenue Rises, Losses Shrink, And Profitability Looms

Accolade (ACCD) Reports Q2 Loss, Tops Revenue Estimates

Zacks

6 months ago

Accolade (ACCD) Reports Q2 Loss, Tops Revenue Estimates

Investing.com

6 months ago

Accolade shares soar on narrower quarterly loss, margin growth

MT Newswires

6 months ago

Top Premarket Gainers

Associated Press Finance

6 months ago

Accolade: Fiscal Q2 Earnings Snapshot

Accolade Announces Results for Fiscal Second Quarter 2025

GlobeNewswire

6 months ago

Accolade Announces Results for Fiscal Second Quarter 2025

Accolade Inc (ACCD) Q2 2025: Everything You Need to Know Ahead of Earnings

GuruFocus.com

6 months ago

Accolade Inc (ACCD) Q2 2025: Everything You Need to Know Ahead of Earnings

With 74% ownership, Accolade, Inc. (NASDAQ:ACCD) boasts of strong institutional backing

Simply Wall St.

6 months ago

With 74% ownership, Accolade, Inc. (NASDAQ:ACCD) boasts of strong institutional backing

Accolade to Announce Fiscal Second Quarter 2025 Financial Results

GlobeNewswire

6 months ago

Accolade to Announce Fiscal Second Quarter 2025 Financial Results

One of the largest blockchain fund of funds has raised over $135 million across two new vehicles

Fortune

6 months ago

One of the largest blockchain fund of funds has raised over $135 million across two new vehicles

All You Need to Know About Accolade (ACCD) Rating Upgrade to Buy

Zacks

7 months ago

All You Need to Know About Accolade (ACCD) Rating Upgrade to Buy

Accolade To Present at Morgan Stanley 22nd Annual Global Healthcare Conference

GlobeNewswire

7 months ago

Accolade To Present at Morgan Stanley 22nd Annual Global Healthcare Conference

First-of-its-kind Healthcare Innovation Provides Synchronized, Customized Whole-Health Strategies

PR Newswire

7 months ago

First-of-its-kind Healthcare Innovation Provides Synchronized, Customized Whole-Health Strategies

Accolade To Present at Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase

GlobeNewswire

8 months ago

Accolade To Present at Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase

Why You Should Retain Xerox (XRX) in Your Portfolio Now

Zacks

8 months ago

Why You Should Retain Xerox (XRX) in Your Portfolio Now

After Plunging -46.98% in 4 Weeks, Here's Why the Trend Might Reverse for Accolade (ACCD)

Zacks

8 months ago

After Plunging -46.98% in 4 Weeks, Here's Why the Trend Might Reverse for Accolade (ACCD)

After Plunging -47.01% in 4 Weeks, Here's Why the Trend Might Reverse for Accolade (ACCD)

Zacks

8 months ago

After Plunging -47.01% in 4 Weeks, Here's Why the Trend Might Reverse for Accolade (ACCD)

Accolade First Quarter 2025 Earnings: Beats Expectations

Simply Wall St.

9 months ago

Accolade First Quarter 2025 Earnings: Beats Expectations

MT Newswires

9 months ago

Sector Update: Health Care

MT Newswires

9 months ago

Top Midday Decliners

MT Newswires

9 months ago

Barclays Lowers Price Target on Accolade to $5.50 From $11, Maintains Equalweight Rating

Accolade Stock on Pace for All-Time Low as Guidance Disappoints. The Case to Buy the Dip.

Barrons.com

9 months ago

Accolade Stock on Pace for All-Time Low as Guidance Disappoints. The Case to Buy the Dip.

MT Newswires

9 months ago

Canaccord Genuity Adjusts Price Target on Accolade to $13 From $16, Maintains Buy Rating

MT Newswires

9 months ago

Needham Cuts Accolade's Price Target to $8 From $13, Keeps Buy Rating

MT Newswires

9 months ago

Top Premarket Decliners

Accolade Stock Sinks After Guidance Disappoints. The Case to Buy the Dip.

Barrons.com

9 months ago

Accolade Stock Sinks After Guidance Disappoints. The Case to Buy the Dip.

Accolade, Inc. (NASDAQ:ACCD) Q1 2025 Earnings Call Transcript

Insider Monkey

9 months ago

Accolade, Inc. (NASDAQ:ACCD) Q1 2025 Earnings Call Transcript

MT Newswires

9 months ago

Morgan Stanley Halves Price Target on Accolade to $6 From $12, Keeps Equalweight Rating

MT Newswires

9 months ago

Truist Adjusts Price Target on Accolade to $9 From $14, Maintains Buy Rating

Investing.com

9 months ago

Nike and Accolade fall premarket; Trump Media and Infinera rise

Accolade (ACCD) Reports Q1 Loss, Tops Revenue Estimates

Zacks

9 months ago

Accolade (ACCD) Reports Q1 Loss, Tops Revenue Estimates

MT Newswires

9 months ago

Accolade Fiscal Q1 Net Loss Narrows, Revenue Rises; Fiscal Q2 Revenue Outlook Set -- Shares Fall After Hours

Associated Press Finance

9 months ago

Accolade: Fiscal Q1 Earnings Snapshot

Accolade Announces Results for Fiscal First Quarter 2025

GlobeNewswire

9 months ago

Accolade Announces Results for Fiscal First Quarter 2025

Is Accolade Inc. (ACCD) a Good Small-Cap Stock to Buy?

Insider Monkey

9 months ago

Is Accolade Inc. (ACCD) a Good Small-Cap Stock to Buy?

Can Accolade (ACCD) Sustain an Annual Revenue Growth Rate of 20%?

Insider Monkey

9 months ago

Can Accolade (ACCD) Sustain an Annual Revenue Growth Rate of 20%?

Accolade to Announce Fiscal First Quarter 2025 Financial Results

GlobeNewswire

9 months ago

Accolade to Announce Fiscal First Quarter 2025 Financial Results

Accolade To Present at William Blair Growth Stock Conference

GlobeNewswire

10 months ago

Accolade To Present at William Blair Growth Stock Conference

Accolade Welcomes Noom to Trusted Partner Ecosystem

PR Newswire

10 months ago

Accolade Welcomes Noom to Trusted Partner Ecosystem

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

Motley Fool

a year ago

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

MT Newswires

a year ago

Wells Fargo Cuts Price Target on Accolade to $10 From $12, Maintains Equalweight Rating

Accolade, Inc. (NASDAQ:ACCD) Q4 2024 Earnings Call Transcript

Insider Monkey

a year ago

Accolade, Inc. (NASDAQ:ACCD) Q4 2024 Earnings Call Transcript

10 Cathie Wood Stocks Insiders are Selling

Insider Monkey

a year ago

10 Cathie Wood Stocks Insiders are Selling

MT Newswires

a year ago

Morgan Stanley Trims Accolade's Price Target to $12 From $13, Maintains Equal Weight Rating

Thomson Reuters StreetEvents

a year ago

Q4 2024 Accolade Inc Earnings Call

GuruFocus.com

a year ago

Accolade Inc (ACCD) Q4 2024 Earnings Call Transcript Highlights: Record Revenue and Strategic ...

Accolade Inc (ACCD) Surpasses Revenue Expectations and Narrows Losses in Fiscal Q4 and Full ...

GuruFocus.com

a year ago

Accolade Inc (ACCD) Surpasses Revenue Expectations and Narrows Losses in Fiscal Q4 and Full ...

Accolade (ACCD) Reports Q4 Loss, Tops Revenue Estimates

Zacks

a year ago

Accolade (ACCD) Reports Q4 Loss, Tops Revenue Estimates

Associated Press Finance

a year ago

Accolade: Fiscal Q4 Earnings Snapshot

Accolade Announces Results for Fiscal Fourth Quarter and Full Year 2024

GlobeNewswire

a year ago

Accolade Announces Results for Fiscal Fourth Quarter and Full Year 2024

Accolade to Announce Fiscal Fourth Quarter 2024 Financial Results

GlobeNewswire

a year ago

Accolade to Announce Fiscal Fourth Quarter 2024 Financial Results

Recent uptick might appease Accolade, Inc. (NASDAQ:ACCD) institutional owners after losing 24% over the past year

Simply Wall St.

a year ago

Recent uptick might appease Accolade, Inc. (NASDAQ:ACCD) institutional owners after losing 24% over the past year

Strength Seen in Paymentus (PAY): Can Its 7.8% Jump Turn into More Strength?

Zacks

a year ago

Strength Seen in Paymentus (PAY): Can Its 7.8% Jump Turn into More Strength?

Accolade Wins 2024 Artificial Intelligence Excellence Award

PR Newswire

a year ago

Accolade Wins 2024 Artificial Intelligence Excellence Award

Accolade Promotes Kelsi McDonald Harris to Chief People Officer

PR Newswire

a year ago

Accolade Promotes Kelsi McDonald Harris to Chief People Officer

Accolade To Present at Upcoming Investor Conferences

GlobeNewswire

a year ago

Accolade To Present at Upcoming Investor Conferences

Accolade Welcomes Brightline to Trusted Partner Ecosystem

PR Newswire

a year ago

Accolade Welcomes Brightline to Trusted Partner Ecosystem

20 Most Valuable Digital Health Companies In The US

Insider Monkey

a year ago

20 Most Valuable Digital Health Companies In The US

Are Business Services Stocks Lagging Accolade (ACCD) This Year?

Zacks

a year ago

Are Business Services Stocks Lagging Accolade (ACCD) This Year?

Does Accolade (ACCD) Have the Potential to Rally 25.58% as Wall Street Analysts Expect?

Zacks

a year ago

Does Accolade (ACCD) Have the Potential to Rally 25.58% as Wall Street Analysts Expect?

$4 Million Bucks Will Buy You This Type of Retirement If You Stop Working at 55

SmartAsset

a year ago

$4 Million Bucks Will Buy You This Type of Retirement If You Stop Working at 55

Reuters

a year ago

Biden's job approval drops to 38% as border worries rise - Reuters/Ipsos

A Massive Problem With Apple Stock Today

Motley Fool

a year ago

A Massive Problem With Apple Stock Today

Brinker International's (NYSE:EAT) Posts Q2 Sales In Line With Estimates

StockStory

a year ago

Brinker International's (NYSE:EAT) Posts Q2 Sales In Line With Estimates

Investors Heavily Search Bank of America Corporation (BAC): Here is What You Need to Know

Zacks

a year ago

Investors Heavily Search Bank of America Corporation (BAC): Here is What You Need to Know

Zacks.com featured highlights include AxoGen, Western Digital, Accolade and Credo Technology Group

Zacks

a year ago

Zacks.com featured highlights include AxoGen, Western Digital, Accolade and Credo Technology Group

Share on Social Networks: